Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$142,786
in 3 filings

Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-04 Leupin Nicolas Chief Medical Officer Grant or award +54,975 $18.19 $1000K 105,108
2025-03-04 Leupin Nicolas Chief Medical Officer Grant or award · Stock Options (Right to buy) +81,499 $18.19 $1.5M 81,499
2025-03-04 Ben Arye Barak General Counsel Grant or award +54,975 $18.19 $1000K 173,696
2025-03-04 Ben Arye Barak General Counsel Grant or award · Stock Options (Right to buy) +81,499 $18.19 $1.5M 81,499
2025-03-04 Puri Michal Nath Chief Human Resources Officer Grant or award +54,975 $18.19 $1000K 163,681
2025-03-04 Puri Michal Nath Chief Human Resources Officer Grant or award · Stock Options (Right to buy) +81,499 $18.19 $1.5M 81,499
2025-03-04 Weinberg Uri Chief Innovation Officer Grant or award +54,975 $18.19 $1000K 221,218
2025-03-04 Weinberg Uri Chief Innovation Officer Grant or award · Stock Options (Right to buy) +81,499 $18.19 $1.5M 81,499
2025-03-04 Leonard Frank X EVP, Pres., Novocure Oncology Grant or award +54,975 $18.19 $1000K 198,648
2025-03-04 Leonard Frank X EVP, Pres., Novocure Oncology Grant or award · Stock Options (Right to buy) +81,499 $18.19 $1.5M 81,499
2025-03-04 Paravasthu Mukund Chief Operating Officer Grant or award +54,975 $18.19 $1000K 84,148
2025-03-04 Paravasthu Mukund Chief Operating Officer Grant or award · Stock Options (Right to buy) +81,499 $18.19 $1.5M 81,499
2025-03-04 Cordova Ashley Chief Executive Officer Grant or award +151,181 $18.19 $2.7M 355,186
2025-03-04 Cordova Ashley Chief Executive Officer Grant or award · Stock Options (Right to buy) +224,123 $18.19 $4.1M 224,123
2025-03-03 Weinberg Uri Chief Innovation Officer Sale −268 $18.92 $5K 166,243
2025-03-03 Leonard Frank X EVP, Pres., Novocure Oncology Sale −2,527 $18.54 $47K 143,673
2025-03-03 Cordova Ashley Chief Executive Officer Sale −2,053 $18.54 $38K 204,005
2025-03-03 Paravasthu Mukund Chief Operating Officer Sale −250 $18.54 $5K 29,173
2025-02-28 Weinberg Uri Chief Innovation Officer Sale −4,326 $18.78 $81K 166,822
2025-02-28 Weinberg Uri Chief Innovation Officer Sale −311 $18.31 $6K 166,511

Page 7 of 9 · 178 trades